Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Solesence (SLSN) Common Equity: 2010-2025

Historic Common Equity for Solesence (SLSN) over the last 14 years, with Sep 2025 value amounting to $17.2 million.

  • Solesence's Common Equity rose 13.57% to $17.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.2 million, marking a year-over-year increase of 13.57%. This contributed to the annual value of $14.9 million for FY2024, which is 685.80% up from last year.
  • Solesence's Common Equity amounted to $17.2 million in Q3 2025, which was down 5.28% from $18.2 million recorded in Q2 2025.
  • Solesence's 5-year Common Equity high stood at $18.2 million for Q2 2025, and its period low was $1.9 million during Q4 2023.
  • Its 3-year average for Common Equity is $10.3 million, with a median of $11.9 million in 2024.
  • In the last 5 years, Solesence's Common Equity crashed by 66.33% in 2023 and then surged by 685.80% in 2024.
  • Quarterly analysis of 5 years shows Solesence's Common Equity stood at $7.5 million in 2021, then dropped by 24.33% to $5.6 million in 2022, then slumped by 66.33% to $1.9 million in 2023, then surged by 685.80% to $14.9 million in 2024, then rose by 13.57% to $17.2 million in 2025.
  • Its last three reported values are $17.2 million in Q3 2025, $18.2 million for Q2 2025, and $15.2 million during Q1 2025.